Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial

BACKGROUND: Nitroglycerin is proposed as an agent to reduce tumour hypoxia by improving tumour perfusion. We investigated the potential of nitroglycerin as a radio-sensitizer in non-small cell lung cancer (NSCLC) and the potential of functional imaging for patient selection. MATERIAL AND METHODS: Tr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Transl Radiat Oncol
Asıl Yazarlar: Reymen, Bart J.T., van Gisbergen, Marike W., Even, Aniek J.G., Zegers, Catharina M.L., Das, Marco, Vegt, Erik, Wildberger, Joachim E., Mottaghy, Felix M., Yaromina, Ala, Dubois, Ludwig J., van Elmpt, Wouter, De Ruysscher, Dirk, Lambin, Philippe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6993056/
https://ncbi.nlm.nih.gov/pubmed/32021913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctro.2019.12.002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller